Content
Prescription weight loss that puts you first
Reviewed by Craig Primack, MD, FACP, FAAP, FOMA
Written by Hadley Mendelsohn
Published 10/30/2023
Updated 10/01/2024
There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight loss. Whether you have type 2 diabetes or obesity, you may have heard about medications like Ozempic® that can help manage blood sugar levels and weight.
So, what’s the best diabetes drug for weight loss? Is there a diabetes shot for weight loss? Are these medications actually effective for weight management, and should they ever be used by people without diabetes?
We’ll help fill some of the gaps, including which FDA-approved diabetes drugs can cause weight loss, how effective they are at reducing and managing body weight, and the possible side effects.
Content
Unless you’ve been living under a rock, you’ve heard of people using diabetes drugs for weight loss.
Diabetes drugs are prescribed alongside lifestyle changes, like a healthy eating plan and increased exercise.
They can impact your weight in several ways. Some diabetes medications make the pancreas produce more insulin, while others lower the body’s production of glucose (blood sugar) — and some even do both. GLP-1s also act on a part of your brain that’s responsible for appetite regulation.
Several types of diabetes medications that may promote weight loss have weight loss as a side effect. These diabetes drugs for weight loss include:
GLP-1s. What are GLP-1 medications? Glucagon-like peptide-1 receptor agonists (GLP-1s for short) are a class of drugs that stimulate the GLP-1 receptor in your pancreas. This leads the pancreas to produce more insulin, which helps lower blood sugar levels and promote weight loss. GLP-1 drugs for weight loss and type 2 diabetes include dulaglutide, liraglutide, and semaglutide.
GIP/GLP-1s. These are dual-acting, meaning they target two receptors in the body: gastric inhibitory polypeptide (GIP) and GLP-1. Besides acting on GLP-1, they mimic GIP. This hormone is released after eating to trigger insulin production and is linked with feelings of fullness. Tirzepatide is a GIP/GLP-1.
Biguanides. These medications help keep your blood sugar in check by making the liver produce less glucose. Metformin is a biguanide.
We’ll break down the different active ingredients in each of these diabetes drug classes ahead.
Semaglutide is a GLP-1 receptor agonist that acts on a hormone affecting appetite regulation. It’s among the most popular diabetes drugs for weight loss.
Novo Nordisk’s brand-name drugs for semaglutide are Ozempic®, Wego vy®, and Rybelsus®. Ozempic and Wegovy are both once-weekly subcutaneous injections, while Rybelsus is taken orally every day.
There are a few other distinctions between each to be aware of.
Most notably, Ozempic was FDA-approved in 2017 to treat type 2 diabetes and is sometimes prescribed off-label to support weight management.
Wegovy was FDA-approved in 2021 for weight loss in people with obesity or those with an overweight BMI (body mass index) who also have an obesity-related condition, like high blood pressure (hypertension) or high cholesterol.
Liraglutide is the active ingredient in Saxenda® and Victoza®.
Like semaglutide, liraglutide is an injected GLP-1 receptor agonist that works by regulating a hunger hormone.
Unlike Ozempic and Wegovy — which are injected once a week — liraglutide is injected once a day. For those who don’t love the idea of a daily injection, semaglutide injections may be the best GLP-1 for weight loss option.
Victoza is FDA-approved to treat type 2 diabetes but is also sometimes prescribed off-label for weight loss. Saxenda is FDA-approved for weight management in people with obesity.
Dulaglutide is another GLP-1 injection available under the brand name Trulicity®. This medication is FDA-approved for type 2 diabetes but is sometimes prescribed off-label for weight loss.
Like semaglutide, this is one of the diabetes drugs for weight loss that’s injected once weekly.
Tirzepatide is the active ingredient in the brand-name drugs Mounjaro® and Zepbound®.
Mounjaro is FDA-approved as a diabetes drug but is also prescribed off-label for weight loss, while Zepbound is FDA-approved for weight loss.
Tirzepatide is a dual-action injection known as a GIP/GLP-1 receptor agonist. According to an Eli Lilly-sponsored study, 10 to 15 milligrams of once-weekly tirzepatide can reduce appetite and food intake, both of which promote weight loss.
Metformin — a biguanide — is an oral diabetes medication that helps keep blood sugar in check by causing the liver to produce less glucose. It was approved by the FDA in 1994 for the treatment of type 2 diabetes.
So, is diabetes medication for weight loss effective? Two recent studies have shown that GLP-1s offer a lot of potential:
A Novo Nordisk-sponsored 2021 study followed nearly 2,000 adults with a body mass index (BMI) of 30 or more and without diabetes. It looked at 2.4 milligrams of weekly semaglutide versus a placebo and found that, on average, semaglutide users lost seven times as much weight as the placebo group over the course of a 68-week treatment.
A 2022 study sponsored by Eli Lilly followed more than 2,500 adults with a BMI of 30 or more and without diabetes. It looked at the effectiveness of tirzepatide for 72 weeks at different doses. In the end, the drug led to significant weight loss across weekly dosages of 5, 10, and 15 milligrams, with a higher dose showing more benefits.
In one study from Novo Nordisk, 846 participants were given either a 1.8-milligram dose of liraglutide, a 3-milligram dose of liraglutide, or a placebo for 56 weeks, all with a 500-calorie per day deficit and increased physical activity. People who took 3 milligrams of liraglutide experienced the most significant weight loss.
A 2020 meta-analysis of 21 metformin trials found the drug had a clinically significant impact on lowering BMI — particularly in folks with obesity.
A smaller study on metformin also found that the average weight lost in 154 patients was between 5.6 and 7 kilograms — or 13 to 15 pounds.
Generally speaking, GLP-1s, GIP/GLP-1s, and metformin are considered safe and effective when used as prescribed.
That said, no medication is without side effects. The most common side effects of GLP-1 medications are gastrointestinal issues, including:
Constipation
Vomiting
Diarrhea
Abdominal pain
Nausea
More serious issues are possible with GLP-1 receptor agonists. Taking these drugs could elevate your risk for:
Kidney disease
Pancreatitis
Thyroid cancer, especially those with multiple endocrine neoplasia
These severe adverse effects of weight loss diabetes drugs are uncommon, but they’re important to keep in mind.
These diabetes drugs all require a prescription. You can meet with a licensed healthcare provider in person or on certain telehealth platforms to get a prescription. This will likely entail an exam, a medical evaluation, and a review of your personal medical history.
Although getting GLP-1s and metformin for weight loss varies by provider, they’ll typically ask you some questions and calculate your BMI. Body mass index is based on your height and weight. It can provide a basic idea of body fat composition.
A one-month supply of brand-name weight loss injections costs around the following, though prices may vary based on your location, your dose, and other factors:
Ozempic: $1,029
Wegovy: $1,430
Mounjaro: $1,335
Victoza: $582
Saxenda: $1,430
Zepbound: $1,126
Trulicity: $1,039
Rybelsus: $1,029
Metformin: $11
Also, health insurance policies don’t usually cover weight loss medications, including semaglutide, liraglutide, and tirzepatide. But they might cover diabetes treatment.
You may want to check out our offerings if you think you might be a good fit for metformin or compounded semaglutide. Hers offers access to safe and affordable compounded semaglutide through licensed providers on our platform. We also offer metformin.
First, you’ll do a virtual health evaluation and have a consultation with a licensed healthcare provider. From there, if appropriate, they’ll prescribe you a medication that aligns with your health needs and goals. The medication will then be delivered to your door in discreet packaging.
You’ll have access to free, ongoing virtual check-ins and provider support to address concerns, help manage any early side effects, and monitor progress.
Pricing options from Hers range. A monthly supply of compounded semaglutide starts as low as $199. Metformin pricing starts at $79 per month. You don’t have to pay for the initial consultation or have health insurance.
Losing weight can be a significant priority for those with overweight and obesity. Carrying excess body weight can lead to medical conditions like high blood pressure, high cholesterol, heart disease, heart attacks, and more.
But reaching a lower body weight can be a complicated process. It’s not always as simple as going on a diet or trying to exercise more — especially if you have a metabolic condition that makes it harder to do so. In some cases, diabetes medications that support weight loss can be game-changing tools.
Here’s what to keep in mind about diabetes drugs for weight loss:
GLP-1s and GIP/GLP-1s treat both obesity and type 2 diabetes. They each function a little differently, but they generally work by keeping blood sugar levels in check and acting on hormones that affect appetite regulation.
The FDA has approved metformin, Ozempic, and Mounjaro to treat diabetes, but these drugs can be prescribed off-label for weight loss.
Saxenda (liraglutide), Wegovy (semaglutide), and Zepbound (tirzepatide) are all approved for chronic weight management in folks with obesity and overweight with accompanying medical conditions like high blood pressure.
Of the diabetes drugs prescribed off-label for weight loss, metformin is one of the most well-researched.
If you have obesity or are struggling to lose weight, talk to a healthcare provider about the potential benefits of weight loss drugs. They can help you figure out the best plan for your personal needs and goals.
Hers offers access to multiple diabetes drugs for weight loss. You can connect with a healthcare provider to discuss possible treatment plans.
Get started on our telehealth weight loss platform today.
Hims & Hers has strict sourcing guidelines to ensure our content is accurate and current. We rely on peer-reviewed studies, academic research institutions, and medical associations. We strive to use primary sources and refrain from using tertiary references. See a mistake? Let us know at [email protected]!